Do You Know How Much Pharma Loses Due to Nonadherence?

Pharma companies lose $188 billion each year because patients don’t take their meds.1 Let’s delve deeper into three specific ideas pharma marketers can use to reduce the medication nonadherence problem. Continue reading…

FacebookTwitter

Infographic on Medication Adherence

This infographic illustrates the prevalence of two types of medication nonadherence and the consequences for patients, the healthcare system and pharmaceuticals. Are you aware of how large this problem is, and the impact it is having on pharmaceutical sales? Continue reading…

FacebookTwitter

The Pharma Executives’ Thanksgiving Blog

In the spirit of Thanksgiving, here are four reasons why pharma execs should thank not just physicians, but the often neglected members of the family: NPs/PAs. Before diving into your Thanksgiving meal, read below how NPs/PAs help pharma marketing execs achieve their business goals. Continue reading…

FacebookTwitter

The Cost of Premature Medication Discontinuation

Stats indicate 6 in 10 don’t take medications as directed including forgetting and intentionally cutting the dose or stopping a medication early. Psychiatrist Dr. Jay Pomerantz observes, “Pharmaceutical companies seem to focus all their advertising and free-sample offers on attracting potential new patients, with almost no attention focused on the problem of premature discontinuation of therapy by persons already taking their medication. Continue reading…

FacebookTwitter

Solving Pharma’s Primary Nonadherence Problem

The CDC reports 20 to 30% of new prescriptions are never filled at the pharmacy (called primary nonadherence). A recent study found an even higher rate: 1/3 of patients failed to fill a first-time prescription. Getting providers to write scripts does little good if patients don’t get them filled. Continue reading…

FacebookTwitter
1 8 9 10 11 12